Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2.
PLOD2
cancer immunity
immune infiltration
pan-cancer analysis
prognostic biomarker
Journal
Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
01
2022
accepted:
07
04
2022
entrez:
19
5
2022
pubmed:
20
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
Some previous studies have shown that
Identifiants
pubmed: 35586565
doi: 10.3389/fgene.2022.864655
pii: 864655
pmc: PMC9108334
doi:
Types de publication
Journal Article
Langues
eng
Pagination
864655Informations de copyright
Copyright © 2022 Xu, Kong, Zhao, Wu, Wang, Xun and Gao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Rev Drug Discov. 2019 Feb;18(2):99-115
pubmed: 30470818
Nat Med. 2015 Aug;21(8):938-945
pubmed: 26193342
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820971670
pubmed: 33161837
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188719
pubmed: 35307354
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Nature. 2020 Feb;578(7793):102-111
pubmed: 32025015
Mol Oncol. 2021 Nov;15(11):2841-2867
pubmed: 33724653
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
Nature. 2020 Feb;578(7793):122-128
pubmed: 32025013
Front Genet. 2021 Feb 22;12:615834
pubmed: 33692828
J Cancer. 2020 Jan 1;11(1):121-131
pubmed: 31892979
Lung Cancer. 2021 Sep;159:84-95
pubmed: 34315093
Nature. 2020 Feb;578(7793):112-121
pubmed: 32025012
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Cancer Discov. 2021 Apr;11(4):933-959
pubmed: 33811125
Biomed Pharmacother. 2017 Jun;90:670-676
pubmed: 28415047
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Genet. 2021 Jun 24;12:661306
pubmed: 34249086
Nature. 2020 Feb;578(7793):129-136
pubmed: 32025019
Pathol Oncol Res. 2021 Mar 29;27:585192
pubmed: 34257533
World J Surg Oncol. 2021 Jul 19;19(1):216
pubmed: 34281542
Front Oncol. 2021 Apr 29;11:672677
pubmed: 33996601
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell. 2018 Apr 5;173(2):283-285
pubmed: 29625045
Cancer Discov. 2021 May;11(5):1067-1081
pubmed: 33504580
Genome Biol. 2016 Oct 20;17(1):218
pubmed: 27765066
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Int J Cancer. 2018 Sep 1;143(5):1202-1211
pubmed: 29603227
Ann Oncol. 2020 Aug;31(8):1011-1020
pubmed: 32387455
Nat Genet. 2021 Jan;53(1):11-15
pubmed: 33398197
Cancer Cell. 2020 Nov 9;38(5):624-625
pubmed: 33171127
Br J Cancer. 2016 Aug 9;115(4):480-9
pubmed: 27415013
Nature. 2020 Feb;578(7793):7-8
pubmed: 32025026
Mol Cancer Res. 2013 May;11(5):456-66
pubmed: 23378577
Nat Commun. 2013;4:2612
pubmed: 24113773
Cancer. 2021 Aug 15;127(16):3029-3030
pubmed: 34086348
Br J Cancer. 2016 Jul 26;115(3):354-63
pubmed: 27310702
J Cancer. 2020 Mar 13;11(12):3467-3475
pubmed: 32284742
Genome Biol. 2017 Nov 15;18(1):220
pubmed: 29141660
Nat Rev Cancer. 2014 Jun;14(6):430-9
pubmed: 24827502
Nat Rev Clin Oncol. 2010 Mar;7(3):153-62
pubmed: 20142816